PAVmed (PAVM) Equity Average (2016 - 2025)

PAVmed's Equity Average history runs 10 years deep, the most recent figure standing at $27.4 million for Q4 2025.

• In Q4 2025, Equity Average rose 722.88% year-over-year to $27.4 million; the TTM figure through Dec 2025 stood at $27.4 million (up 722.88% YoY), while the FY2025 annual figure was $9.9 million, up 174.7% from the prior year.
• Equity Average was $27.4 million for Q4 2025 at PAVmed, down from $30.3 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $72.1 million in Q1 2022 to a low of -$22.3 million in Q1 2024.
• Historically, Equity Average has averaged $19.9 million across 5 years, with a median of $21.8 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Equity Average soared 852.61% in 2021, then tumbled 493.19% in 2024.
• A 5-year view of Equity Average shows it stood at $57.3 million in 2021, then sank by 65.56% to $19.7 million in 2022, then tumbled by 200.9% to -$19.9 million in 2023, then soared by 116.72% to $3.3 million in 2024, then soared by 722.88% to $27.4 million in 2025.
• The last three Equity Average figures came in at $27.4 million (Q4 2025), $30.3 million (Q3 2025), and $33.5 million (Q2 2025), per Business Quant data.